0
Articles |

Prognosis of Pulmonary Arterial Hypertension*: ACCP Evidence-Based Clinical Practice Guidelines

Vallerie V. McLaughlin, MD, FCCP; Kenneth W. Presberg, MD, FCCP; Ramona L. Doyle, MD, FCCP; Steven H. Abman, MD; Douglas C. McCrory, MD, MHSc; Terry Fortin, MD; Gregory Ahearn, MD
Author and Funding Information

From the University of Michigan (Dr. McLaughlin), Ann Arbor, MI; Medical College of Wisconsin (Dr. Presberg), Milwaukee, WI; Stanford University (Dr. Doyle), Stanford, CA; University of Colorado Health Sciences Center (Dr. Abman), The Children’s Hospital, Denver, CO; and Duke University Medical Center (Drs. McCrory, Fortin, and Ahearn), Durham, CA.

Correspondence to: Vallerie V. McLaughlin, MD, FCCP, University of Michigan, 1500 East Medical Center Dr, Women’s Hospital-Room L3119, Ann Arbor, MI 48109-0273; e-mail: vmclaugh@umich.edu



Chest. 2004;126(1_suppl):78S-92S. doi:10.1378/chest.126.1_suppl.78S
Text Size: A A A
Published online

Although idiopathic pulmonary arterial hypertension is perceived as a progressive disease with a uniformly poor outcome, the natural history of disease is heterogeneous, with some patients dying within months of diagnosis and others living for decades. The course of the disease has also been altered by advances in medical therapies. The outcome of patients with other types of pulmonary arterial hypertension (PAH) has been less well characterized. Assessment of prognosis of such patients is important, as it influences both medical therapy and referral for transplantation. This chapter will provide evidence based recommendations to assess the prognosis of patients with PAH.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
Medical Therapy For Pulmonary Arterial Hypertension*: ACCP Evidence-Based Clinical Practice Guidelines
Medical Therapy for Pulmonary Arterial Hypertension*: Updated ACCP Evidence-Based Clinical Practice Guidelines
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543